Tsuruha Holdings Inc. (TSUSF)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Tsuruha Holdings Inc. (TSUSF) with AI Score 49/100 (Weak). Tsuruha Holdings Inc. operates drugstores in Japan, selling pharmaceutical and cosmetic products. Market cap: 0, Sector: Healthcare.
Last analyzed: Mar 16, 2026Tsuruha Holdings Inc. (TSUSF) Healthcare & Pipeline Overview
Tsuruha Holdings Inc., a Japanese drugstore chain established in 1929, operates over 2,400 stores in Japan and a smaller presence in Thailand. With a focus on pharmaceutical and cosmetic products, the company maintains a steady profit margin and dividend yield within the competitive healthcare retail sector.
Investment Thesis
Tsuruha Holdings Inc. presents a stable investment profile within the Japanese healthcare retail sector, supported by a P/E ratio of 15.60 and a dividend yield of 2.17%. The company's consistent profitability, demonstrated by a 3.1% profit margin and 30.2% gross margin, underpins its financial health. Growth catalysts include further expansion within Japan and Southeast Asia, leveraging its established brand and operational expertise. However, potential risks include increasing competition from other drugstore chains and evolving consumer preferences. The company's low beta of 0.22 suggests relatively low volatility compared to the broader market.
Based on FMP financials and quantitative analysis
Key Highlights
- Market capitalization of $4.20 billion, reflecting its established position in the Japanese drugstore market.
- P/E ratio of 15.60, indicating a potentially reasonable valuation compared to earnings.
- Profit margin of 3.1%, demonstrating consistent profitability in a competitive retail environment.
- Gross margin of 30.2%, reflecting efficient cost management in its supply chain and retail operations.
- Dividend yield of 2.17%, providing a steady income stream for investors.
Competitors & Peers
Strengths
- Established brand and reputation in Japan.
- Extensive store network.
- Consistent profitability.
- Strong relationships with suppliers.
Weaknesses
- Limited international presence.
- Dependence on the Japanese market.
- Potential vulnerability to changing consumer preferences.
- Exposure to regulatory changes in the healthcare sector.
Catalysts
- Expansion of store network in Japan and Southeast Asia.
- Growth in e-commerce and online retail sales.
- Development and launch of new private label products.
- Potential strategic partnerships with healthcare providers or insurance companies.
- Integration of wellness services into store offerings.
Risks
- Increasing competition from other drugstore chains in Japan.
- Economic downturn in Japan or Southeast Asia affecting consumer spending.
- Changes in government regulations impacting the pharmaceutical industry.
- Fluctuations in currency exchange rates affecting international operations.
- Limited liquidity and transparency due to trading on the OTC market.
Growth Opportunities
- Expansion in Southeast Asia: Tsuruha has a small presence in Thailand with 22 stores as of October 2021. Expanding further into Thailand and other Southeast Asian markets like Vietnam, Indonesia, and the Philippines, which have rapidly growing economies and healthcare needs, could significantly increase revenue. The Southeast Asian drugstore market is projected to reach $30 billion by 2030, presenting a substantial growth opportunity.
- Enhanced E-commerce Platform: Investing in and expanding its online retail presence can unlock new revenue streams and cater to a broader customer base. The e-commerce market in Japan is experiencing double-digit growth, and a robust online platform would allow Tsuruha to compete more effectively with online retailers and other drugstore chains with established e-commerce operations. A target would be to grow online sales by 20% annually over the next 3 years.
- Strategic Partnerships: Collaborating with healthcare providers, insurance companies, and pharmaceutical manufacturers can create synergistic opportunities. Partnerships can lead to exclusive product offerings, integrated healthcare services, and enhanced customer loyalty. For example, partnering with local clinics to offer prescription delivery services or collaborating with insurance companies to provide discounts on health-related products could drive customer acquisition and retention.
- Private Label Expansion: Developing and expanding its private label product offerings can improve profit margins and enhance brand loyalty. Private label products typically offer higher margins compared to branded products, and a well-curated private label portfolio can cater to price-sensitive consumers and differentiate Tsuruha from its competitors. Aim to increase private label sales to 15% of total revenue over the next 5 years.
- Focus on Wellness Services: Integrating wellness services such as health check-ups, nutritional counseling, and beauty consultations into its store offerings can attract new customers and increase customer engagement. As consumers become more health-conscious, offering these value-added services can position Tsuruha as a comprehensive healthcare and wellness destination. The wellness services market is projected to grow by 8% annually over the next 5 years.
Opportunities
- Expansion into Southeast Asian markets.
- Growth in e-commerce and online retail.
- Strategic partnerships with healthcare providers.
- Development of private label products.
Threats
- Increasing competition from other drugstore chains.
- Economic downturn in Japan or Southeast Asia.
- Changes in government regulations affecting the pharmaceutical industry.
- Fluctuations in currency exchange rates.
Competitive Advantages
- Established brand recognition and reputation in the Japanese drugstore market.
- Extensive network of stores providing convenient access to customers.
- Strong relationships with pharmaceutical manufacturers and suppliers.
- Loyal customer base built on trust and service.
About TSUSF
Founded in 1929 and headquartered in Sapporo, Japan, Tsuruha Holdings Inc. has grown to become a prominent drugstore operator in Japan. The company's core business revolves around the retail sale of pharmaceutical products, cosmetics, and general merchandise through its extensive network of stores. As of October 15, 2021, Tsuruha operated 2,448 stores across Japan and 22 stores in Thailand, marking its expansion into Southeast Asia. The company's evolution reflects the changing landscape of the Japanese healthcare and retail sectors, adapting to consumer needs and preferences over the decades. Tsuruha's commitment to providing accessible healthcare and beauty solutions has solidified its position in the market, catering to a diverse customer base seeking both essential and discretionary products. The company emphasizes customer service and convenience, aiming to be a trusted community pharmacy and retail destination.
What They Do
- Operates a chain of drugstores in Japan.
- Sells pharmaceutical products, including prescription and over-the-counter medications.
- Offers a wide range of cosmetic products, including skincare, makeup, and personal care items.
- Provides health and wellness products, such as vitamins, supplements, and medical devices.
- Sells general merchandise, including household goods, food, and beverages.
- Operates a small number of stores in Thailand.
Business Model
- Generates revenue through the retail sale of pharmaceutical, cosmetic, and general merchandise products.
- Maintains a network of physical stores in Japan and Thailand.
- Focuses on providing convenient access to healthcare and beauty products for consumers.
- Emphasizes customer service and a wide product assortment to attract and retain customers.
Industry Context
Tsuruha Holdings Inc. operates within the competitive Japanese drugstore market, characterized by a mix of national chains and regional players. The industry is influenced by an aging population, increasing healthcare awareness, and evolving consumer preferences for health and beauty products. The market is witnessing a growing demand for over-the-counter medications, health supplements, and cosmetic products. Tsuruha competes with other major drugstore chains like ARRJF (Matsumotokiyoshi Holdings Co., Ltd.) and ELEAF (Welcia Holdings Co., Ltd.), focusing on strategic store locations, product assortment, and customer service to maintain its market share.
Key Customers
- General consumers seeking pharmaceutical products, cosmetics, and general merchandise.
- Individuals requiring prescription medications and healthcare products.
- Customers looking for health and beauty solutions.
- Local communities served by its network of stores.
Financials
Chart & Info
Tsuruha Holdings Inc. (TSUSF) stock price: Price data unavailable
Latest News
No recent news available for TSUSF.
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for TSUSF.
Price Targets
Wall Street price target analysis for TSUSF.
MoonshotScore
What does this score mean?
The MoonshotScore rates TSUSF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Competitors & Peers
Leadership: Jun Tsuruha
CEO
Jun Tsuruha serves as the CEO of Tsuruha Holdings Inc., leading a workforce of 11,620 employees. Information regarding his detailed career history and educational background is not available in the provided data. However, as CEO, he is responsible for the overall strategic direction and operational performance of the company, guiding its growth and expansion in the competitive drugstore market.
Track Record: As CEO, Jun Tsuruha is responsible for overseeing Tsuruha Holdings Inc.'s operations, which include managing over 2,400 stores in Japan and a smaller number in Thailand. Under his leadership, the company has maintained a consistent profit margin and dividend yield. Specific strategic decisions and milestones achieved under his tenure are not detailed in the provided data.
TSUSF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Tsuruha Holdings Inc. may not meet the minimum financial or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and may not be subject to the same level of regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries higher risks due to the potential for limited information and liquidity.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited liquidity due to low trading volume on the OTC market.
- Lack of transparency and potentially limited financial disclosure.
- Higher price volatility compared to stocks listed on major exchanges.
- Potential for manipulation and fraud due to less regulatory oversight.
- Difficulty in obtaining reliable information about the company's operations and financial performance.
- Verify the company's financial statements and audit reports.
- Research the company's management team and their track record.
- Assess the company's competitive position and market share.
- Understand the regulatory environment in which the company operates.
- Evaluate the company's growth prospects and potential risks.
- Check for any legal or regulatory issues involving the company.
- Consult with a financial advisor before investing.
- Established history as a drugstore operator in Japan since 1929.
- Extensive network of stores in Japan and Thailand.
- Consistent profitability and dividend yield.
- Compliance with Japanese regulations for drugstore operations.
- Presence in the healthcare sector, providing essential products and services.
Tsuruha Holdings Inc. Healthcare Stock: Key Questions Answered
What does Tsuruha Holdings Inc. do?
Tsuruha Holdings Inc. operates a chain of drugstores primarily in Japan, with a smaller presence in Thailand. The company generates revenue by selling a variety of products, including prescription and over-the-counter medications, cosmetic products, health and wellness items, and general merchandise. Tsuruha focuses on providing convenient access to healthcare and beauty solutions for consumers through its extensive network of physical stores and, increasingly, its online retail platform. The company aims to be a trusted community pharmacy and retail destination.
What do analysts say about TSUSF stock?
Analyst consensus on TSUSF stock is not available in the provided data. However, key valuation metrics include a P/E ratio of 15.60 and a dividend yield of 2.17%. Growth considerations include the company's expansion plans in Southeast Asia, its focus on e-commerce, and its development of private label products. Investors should conduct their own research and consider their individual risk tolerance before making any investment decisions.
What are the main risks for TSUSF?
The main risks for Tsuruha Holdings Inc. include increasing competition from other drugstore chains in Japan, potential economic downturns in Japan or Southeast Asia, and changes in government regulations affecting the pharmaceutical industry. Additionally, fluctuations in currency exchange rates could impact the company's international operations. Trading on the OTC market also presents risks related to limited liquidity and transparency.
What are the key factors to evaluate for TSUSF?
Tsuruha Holdings Inc. (TSUSF) currently holds an AI score of 49/100, indicating low score. Key strength: Established brand and reputation in Japan. Primary risk to monitor: Increasing competition from other drugstore chains in Japan. This is not financial advice.
How frequently does TSUSF data refresh on this page?
TSUSF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven TSUSF's recent stock price performance?
Recent price movement in Tsuruha Holdings Inc. (TSUSF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Established brand and reputation in Japan. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider TSUSF overvalued or undervalued right now?
Determining whether Tsuruha Holdings Inc. (TSUSF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying TSUSF?
Before investing in Tsuruha Holdings Inc. (TSUSF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on data available as of 2021-10-15. More current data may alter the analysis.
- OTC market data may be less reliable than major exchange data.